• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分布性成本效益分析:教程

Distributional Cost-Effectiveness Analysis: A Tutorial.

作者信息

Asaria Miqdad, Griffin Susan, Cookson Richard

机构信息

Centre for Health Economics, University of York, York, UK (MA, SG, RC).

出版信息

Med Decis Making. 2016 Jan;36(1):8-19. doi: 10.1177/0272989X15583266. Epub 2015 Apr 23.

DOI:10.1177/0272989X15583266
PMID:25908564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4853814/
Abstract

Distributional cost-effectiveness analysis (DCEA) is a framework for incorporating health inequality concerns into the economic evaluation of health sector interventions. In this tutorial, we describe the technical details of how to conduct DCEA, using an illustrative example comparing alternative ways of implementing the National Health Service (NHS) Bowel Cancer Screening Programme (BCSP). The 2 key stages in DCEA are 1) modeling social distributions of health associated with different interventions, and 2) evaluating social distributions of health with respect to the dual objectives of improving total population health and reducing unfair health inequality. As well as describing the technical methods used, we also identify the data requirements and the social value judgments that have to be made. Finally, we demonstrate the use of sensitivity analyses to explore the impacts of alternative modeling assumptions and social value judgments.

摘要

分布成本效益分析(DCEA)是一个将健康不平等问题纳入卫生部门干预措施经济评估的框架。在本教程中,我们通过一个比较实施国民医疗服务体系(NHS)肠癌筛查计划(BCSP)的不同方式的示例,描述了如何进行DCEA的技术细节。DCEA的两个关键阶段是:1)对与不同干预措施相关的健康社会分布进行建模,以及2)根据改善总体人群健康和减少不公平健康不平等这两个双重目标,评估健康的社会分布。除了描述所使用的技术方法外,我们还确定了数据要求以及必须做出的社会价值判断。最后,我们展示了如何使用敏感性分析来探索替代建模假设和社会价值判断的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa1/4853814/9692cedf34f9/10.1177_0272989X15583266-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa1/4853814/38e2d41e86ad/10.1177_0272989X15583266-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa1/4853814/747cfc5f57a1/10.1177_0272989X15583266-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa1/4853814/048989947297/10.1177_0272989X15583266-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa1/4853814/9692cedf34f9/10.1177_0272989X15583266-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa1/4853814/38e2d41e86ad/10.1177_0272989X15583266-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa1/4853814/747cfc5f57a1/10.1177_0272989X15583266-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa1/4853814/048989947297/10.1177_0272989X15583266-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fa1/4853814/9692cedf34f9/10.1177_0272989X15583266-fig4.jpg

相似文献

1
Distributional Cost-Effectiveness Analysis: A Tutorial.分布性成本效益分析:教程
Med Decis Making. 2016 Jan;36(1):8-19. doi: 10.1177/0272989X15583266. Epub 2015 Apr 23.
2
Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.医疗保健项目的分布成本效益分析——以英国肠癌筛查项目为例的方法学研究
Health Econ. 2015 Jun;24(6):742-54. doi: 10.1002/hec.3058. Epub 2014 May 2.
3
Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.非小细胞肺癌治疗的分布成本效益分析:综合分析及其关键驱动因素的说明。
Pharmacoeconomics. 2023 Aug;41(8):1011-1025. doi: 10.1007/s40273-023-01281-8. Epub 2023 Jun 9.
4
Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia.在中低收入国家进行的分布成本效益分析:以埃塞俄比亚轮状病毒疫苗接种为例。
Health Policy Plan. 2018 Apr 1;33(3):456-463. doi: 10.1093/heapol/czx175.
5
Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.将公平性问题纳入成本效益分析中:系统文献回顾。
Pharmacoeconomics. 2022 Jan;40(1):45-64. doi: 10.1007/s40273-021-01094-7. Epub 2021 Oct 29.
6
Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.健康技术的综合分布成本效益分析。
Value Health. 2019 May;22(5):518-526. doi: 10.1016/j.jval.2019.03.006.
7
Equity and economic evaluation of system-level health interventions: A case study of Brazil's Family Health Program.系统层面卫生干预措施的公平性和经济评价:以巴西家庭健康计划为例。
Health Policy Plan. 2021 Apr 21;36(3):229-238. doi: 10.1093/heapol/czaa181.
8
Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis.社会经济差异对分布成本效益分析的影响。
Med Decis Making. 2020 Jul;40(5):606-618. doi: 10.1177/0272989X20935883. Epub 2020 Jul 1.
9
Aggregate distributional cost-effectiveness analysis: a novel tool for health economic evaluation to inform resource allocation.总体分布成本效益分析:一种用于卫生经济评估以指导资源分配的新工具。
Glob Health Res Policy. 2025 Apr 16;10(1):17. doi: 10.1186/s41256-025-00415-z.
10
Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions.干预对健康不平等影响的不确定性分析,以用于资源分配决策。
Med Decis Making. 2021 Aug;41(6):653-666. doi: 10.1177/0272989X211009883. Epub 2021 Jun 8.

引用本文的文献

1
Efficiency and equity of community-based falls prevention pathways: a model-based health economic evaluation.基于社区的跌倒预防路径的效率与公平性:基于模型的健康经济评估
Age Ageing. 2025 Aug 1;54(8). doi: 10.1093/ageing/afaf212.
2
Efficiency in health care: connecting economic evaluations with implementation objectives.医疗保健中的效率:将经济评估与实施目标联系起来。
Implement Sci Commun. 2025 Jul 26;6(1):77. doi: 10.1186/s43058-025-00763-4.
3
Enhancing Naloxone Distribution for Opioid Users in the USA: A Cost-Utility Analysis of Academic Detailing to Clinicians.

本文引用的文献

1
Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.医疗保健项目的分布成本效益分析——以英国肠癌筛查项目为例的方法学研究
Health Econ. 2015 Jun;24(6):742-54. doi: 10.1002/hec.3058. Epub 2014 May 2.
2
Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.初级保健认可信和患者传单以提高结直肠癌筛查参与率:一项两因素随机试验的结果。
Br J Cancer. 2011 Aug 9;105(4):475-80. doi: 10.1038/bjc.2011.255.
3
Unfair inequalities in health and health care.
在美国为阿片类药物使用者增加纳洛酮的分发:对临床医生进行学术推广的成本效用分析。
Appl Health Econ Health Policy. 2025 Jul 20. doi: 10.1007/s40258-025-00991-8.
4
Inequalities in Quality-Adjusted Life Expectancy in Australia by Educational Attainment.澳大利亚按教育程度划分的质量调整生命预期不平等情况。
Pharmacoeconomics. 2025 Jun 16. doi: 10.1007/s40273-025-01517-9.
5
College of Occupational Therapy - Research Priority 10: What is the cost-effectiveness of Occupational Therapy services? Making the economic case for Occupational Therapy.职业治疗学院 - 研究重点10:职业治疗服务的成本效益如何?阐述职业治疗的经济理由。
Br J Occup Ther. 2025 Jun;88(6):329-332. doi: 10.1177/03080226241304253. Epub 2024 Dec 23.
6
Are Economic Evaluations of Task Shifting Too Narrow in Focus? A Rapid Review.任务转移的经济评估是否聚焦过窄?一项快速综述。
Pharmacoeconomics. 2025 May 23. doi: 10.1007/s40273-025-01507-x.
7
Application of distributional cost-effectiveness analysis methodology in real-world studies: a scoping review protocol.分布成本效益分析方法在真实世界研究中的应用:一项范围综述方案
BMJ Open. 2025 May 12;15(5):e099673. doi: 10.1136/bmjopen-2025-099673.
8
Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity.基因组医学中的分布成本效益分析:解决健康公平问题的考量因素
Value Health. 2025 May 6. doi: 10.1016/j.jval.2025.04.2162.
9
Diabetic Retinopathy Screening Among at Risk Populations: Protocol for Distributional Cost-Effectiveness Analysis.高危人群中的糖尿病视网膜病变筛查:分布成本效益分析方案
JMIR Res Protoc. 2025 Apr 30;14:e60488. doi: 10.2196/60488.
10
Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A : A Cost-Effectiveness Analysis.预防性每周一次艾美赛珠单抗α与标准护理因子VIII用于重度A型血友病患者的成本效益分析
Ann Intern Med. 2025 Jun;178(6):819-828. doi: 10.7326/ANNALS-24-02749. Epub 2025 Apr 22.
健康及医疗保健方面存在的不公平不平等现象。
J Health Econ. 2009 Jan;28(1):73-90. doi: 10.1016/j.jhealeco.2008.07.016. Epub 2008 Aug 20.
4
Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening.一项促进结直肠癌筛查的低强度患者导向干预措施的成本及成本效益
J Clin Oncol. 2007 Nov 20;25(33):5248-53. doi: 10.1200/JCO.2007.13.4098.
5
Review of methods for estimating life expectancy by social class using the ONS Longitudinal Study.使用英国国家统计局纵向研究评估社会阶层预期寿命的方法综述。
Health Stat Q. 2007 Autumn(35):28-36.
6
Option appraisal of population-based colorectal cancer screening programmes in England.英格兰基于人群的结直肠癌筛查项目的方案评估
Gut. 2007 May;56(5):677-84. doi: 10.1136/gut.2006.095109. Epub 2006 Dec 1.